DJIA 16,646.19 31.38 0.19%
NASDAQ 4,426.25 6.77 0.15%
S&P 500 1,944.01 2.73 0.14%
market minute promo


8.17 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PDLI $8.17 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.19
Previous Close $8.17
Daily Range $8.06 - $8.21
52-Week Range $7.22 - $10.26
Market Cap $1.3B
P/E Ratio 4.98
Dividend (Yield) $0.60 (7.3%)
Ex-Dividend Date
Dividend Pay Date
Volume 366,041
Average Daily Volume 3,822,190
Current FY EPS $2.44





PDL BioPharma (PDLI) Description

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses. Website:

News & Commentary

3 Reasons Why Shorts Are Moving into Durata Therapeutics

Despite a recent FDA approval of Durata's new antibiotic Dalvance for acute bacterial skin and skin structure infections, shorts have steadily increased their position in the stock. Here's what you need to know.

Monday's ETF with Unusual Volume: IYH

Weakness Seen in Galena Biopharma (GALE) Estimates: Should You Stay Away? - Tale of the Tape

Weakness Seen in Galena Biopharma (GALE) Estimates: Should You Stay Away? - Tale of the Tape

Emergent BioSolutions Revamps Business to Drive Earnings - Analyst Blog

Regeneron's Eye Drug Eylea Wins Another FDA Approval - Analyst Blog

Alnylam Begins New Study on Hepatic Porphyrias Patients - Analyst Blog

Incyte Receives $60M Milestone Payment Related to Jakavi - Analyst Blog

My 3 Favorite Small Caps That Now Trade At A Discount

Raptor Pharmaceuticals (RPTP) Crumbles: Stock Falls by 7.2% - Tale of the Tape

First Week of PDLI May 2015 Options Trading

5 Healthcare Stocks With The Highest Operating Margin

See More PDLI News...

PDLI's Top Competitors

PDLI $8.17 (0.00%)
Current stock: PDLI
AMGN $142.63 (-1.01%)
Current stock: AMGN
GILD $105.71 (-0.90%)
Current stock: GILD
BIIB $300.95 (-7.90%)
Current stock: BIIB